Given the far flung reaches of Millipore, is it the most complex acquisition Merck has taken on?
The short answer is no. Each merger is complex. Millipore is a proud company, a successful company. We’re both confident and have our own cultures. It’s merging the cultures, not the business decision, that is the most difficult. We are two strong characters with personality and I’m sure we can learn from one another. In making a big acquisition on the instruments side, is that an effort to blunt against what is expected to be a tough couple of years for pharma, with drugs coming off patent and dwindling pipelines? We’ve always been a hybrid company with a commitment to both the pharmaceutical side and the chemical side. But in the past we hadn’t had many instruments, so it helps us widen our focus. But it doesn’t take away from our pharma business. I strongly believe that an innovative pharma business has a future, and I’m very confident in our pipeline. We did the Serono acquisition (in 2007) on the pharma side, and now this acquisition, both to have a greater global reach to satisfy
Related Questions
- Given the severe disruption this project will cause for downtown, ODU, and the Medical Center Complex, has the city required the repairs to be done on a 24/7 (around the clock) time schedule?
- Given that a regression analysis is a complex process, not all contractors will be able to undertake one in order to comply with the Voluntary Guidelines. What should these contractors do?
- My son had primary complex when he was ten months old and was given medication for 6 months and he is now 9 years old. My question is, does primary complex leave a scar on the lungs?
